Archive: 2026/02 - Page 2

Restless Legs Syndrome: Dopaminergic Medications Risks and Modern Relief Options
Orson Bradshaw 5 February 2026 14 Comments

Restless Legs Syndrome affects 5-10% of adults. New guidelines show dopamine agonists are no longer first-line due to augmentation risks. Alpha-2-delta ligands like pregabalin are now preferred. Lifestyle changes and iron supplements also help manage symptoms.

Read More
PCSK9 Inhibitors vs Statins: Side Effects, Effectiveness, and Cost Comparison
Orson Bradshaw 4 February 2026 10 Comments

PCSK9 inhibitors and statins are two cholesterol-lowering treatments with distinct benefits and risks. Statins are widely used but can cause muscle pain. PCSK9 inhibitors offer stronger LDL reduction and avoid muscle issues but cost more. Learn how they compare for side effects and outcomes.

Read More
FDA Generic Approval Changes 2023-2025: What Manufacturers and Patients Need to Know
Orson Bradshaw 2 February 2026 10 Comments

The FDA's 2023-2025 overhaul of generic drug approvals prioritizes U.S.-made medications to fix supply chain gaps. Learn how the new pilot program speeds up approvals, impacts drug prices, and affects manufacturers and patients.

Read More
HIV Medications with Statins: Safe Choices and Side Effects
Orson Bradshaw 1 February 2026 14 Comments

Combining HIV medications with statins can be dangerous without proper knowledge. Learn which statins are safe, which to avoid, dosing limits, monitoring tips, and how to prevent life-threatening muscle damage.

Read More